David Raimer, MD
Procedural Dermatology · Galveston, TXNPI 1598956781
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 12.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $555, more than ten times the $12 reported in 2019. That places this record below the midpoint for procedural dermatology clinicians in TX, where the typical reported total is $2,420.
Across 36 payments — averaging $23.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$105
- Revance Therapeutics, Inc.$94
- Pfizer$87
- Arcutis Biotherapeutics, Inc.$72
- Novartis$66
- AbbVie$59
- plus $370 from 15 others
What the payments were for
- Food & beverage$853100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 3 | $105 |
| Revance Therapeutics, Inc. | 1 | $94 |
| Pfizer | 5 | $87 |
| Arcutis Biotherapeutics, Inc. | 4 | $72 |
| Novartis | 4 | $66 |
| AbbVie | 2 | $59 |
| Elekta, Inc. | 1 | $51 |
| Biofrontera Inc. | 2 | $48 |
| E.r. Squibb & Sons, L.L.C. | 2 | $41 |
| Amgen | 1 | $29 |
| Incyte Corporation | 1 | $26 |
| Johnson & Johnson | 1 | $24 |
| Lilly USA, LLC | 1 | $23 |
| Verrica Pharmaceuticals Inc. | 1 | $20 |
| Galderma Laboratories, L.p. | 1 | $18 |
| Strata Skin Sciences, Inc. | 1 | $17 |
| Organogenesis Inc. | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Sanofi | 1 | $15 |
| Merz North America, Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $12 |
How this compares
$853 in reported general payments places this provider in the 25th percentile of 25 procedural dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 92 | $2,881 |
| Fluocinonide | 55 | $1,808 |
| Fluorouracil | 23 | $1,339 |
| Triamcinolone Acetonide | 151 | $1,324 |
| Ketoconazole | 74 | $1,178 |
| Metronidazole | 40 | $1,173 |
| Doxycycline Hyclate | 95 | $1,077 |
| Betamethasone Dipropionate | 16 | $590 |
| Mometasone Furoate | 32 | $486 |
| Fluticasone Propionate | 30 | $447 |
| Ciclopirox | 13 | $258 |
| Minocycline Hcl | 14 | $246 |
| Ammonium Lactate | 15 | $239 |
| Clindamycin Phosphate | 16 | $216 |
| Hydrocortisone | 50 | $175 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Galveston
- Daniel FriedmannAustin$146K
- Liet leKingwood$90K
- Jean-Denis BoucherLive Oak$20K
- Tho NguyenHurst$16K
- Douglas FarrisHurst$16K
- Robert OchsSan Antonio$11K
- Farhad NiroomandDallas$9K
- Laura SearsDallas$8K
- Georganna DavisHouston$8K
- Paige HoyerEl Campo$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.